BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

BLAST Shows Superior Prognostic Accuracy for Survival Compared to CPSS in Chinese Patients with Chronic Myelomonocytic Leukemia

  • By

  • Xin Yan

  • Gege Feng

  • Zhimei Cai

  • Jiale Ma

  • Shuqian Xu

  • Zheng Ge

  • June 17, 2026

Share

Original Source(s)

BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia

  • by Xin Yan, Gege Feng, Zhimei Cai, Jiale Ma, Shuqian Xu, Zheng Ge

  • June 17, 2026

Related Content

Correction: Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer

Establishment and clinical performance evaluation of the thyroglobulin colloidal gold immunochromatographic assay

Efficiency and Sustainability in the Skin Cancer Excision Pathway: Life Cycle Assessment and Process Map